Total Liabilities: The total value of all possible claims against the corporation.
Bioxytran, Inc. (BIXT) had Total Liabilities of $5.27M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.62M |
|
-- |
|
-- |
|
$0.65M |
|
$-0.65M |
|
$0.03M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.65M |
|
$-0.65M |
|
114.36M |
|
114.36M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.18M |
|
-- |
|
$0.16M |
|
$0.33M |
|
$5.27M |
|
-- |
|
-- |
|
|
Total Liabilities |
$5.27M |
$-4.98M |
|
$-5.10M |
|
$-4.94M |
|
114.70M |
|
| Cash Flow Statement Financials | |
$-0.59M |
|
$-0.02M |
|
$0.27M |
|
$0.51M |
|
$0.18M |
|
$-0.33M |
|
$1.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.44% |
|
12.16% |
|
-185.95% |
|
12.55% |
|
$-0.04 |
|
$-0.01 |
|
$-0.01 |
|